answersLogoWhite

0


Best Answer

Myasthenia gravis

User Avatar

Wiki User

12y ago
This answer is:
User Avatar
More answers
User Avatar

AnswerBot

1mo ago

Myasthenia gravis is a neuromuscular disorder characterized by muscle weakness and fatigue, typically worsening with activity and improving with rest. It is caused by an autoimmune response that targets acetylcholine receptors at the neuromuscular junction, leading to impaired communication between nerves and muscles. Treatment often involves medications that help improve nerve impulse transmission and reduce symptoms.

This answer is:
User Avatar

Add your answer:

Earn +20 pts
Q: What is a neuromuscular disorder characterized by relapsing weakness of skeletal muscles?
Write your answer...
Submit
Still have questions?
magnify glass
imp
Related questions

What is a chronic progressive neuromuscular disorder that causes severe skeletal muscle weakness?

myasthenia gravis


What type of muscle tissue has neuromuscular junctions?

skeletal muscle


Action potentials are conducted into a skeletal muscle fiber by?

C. neuromuscular junctions


Each skeletal muscle fiber is controlled by a motor neuron at a single?

neuromuscular junction


Skeletal muscle fiber contraction begins when?

Acetylcholine is released into the neuromuscular junction by the axon terminal


What is the narrow space that separates the motor neuron and the skeletal muscle fiber in a neuromuscular junction called?

Neuromuscular junction or neuromuscular synapse


Which of these junctions represents the connection between the tip of a neuron and a skeletal muscle cell from which Acetylcholine diffuses?

Neuromuscular


Is bone tumor bone cyst hypophosphatasia osteomalacia haematopoiesis or osteoporosis a skeletal disorder?

Hypophosphatasia is a metabolic disorder that can cause skeletal deformities.


Which disorder has to do with women and the skeletal system?

osteoporosis


What is the point of contact between a motor neuron and a skeletal muscle cell called?

This point is often called the neuromuscular junction or motor end plate. ?The neurotransmitter used here is acetylcholine.Many diseases occur with dysfunction at this junction, like Myesthenia Gravis, botulism, or Lambert Eaton Myasthenic Syndrome.


The axon terminals of a nerve cell and the sarcolemma of a skeletal muscle cell join at the?

The axon terminals of a nerve cell and the sarcolemma of a skeletal muscle cell join at the neuromuscular junction. This is where the nerve impulse triggers the release of neurotransmitters, such as acetylcholine, which initiate muscle contraction by binding to receptors on the sarcolemma.


What does curare act by in the neuromuscular junction?

Curare acts by blocking nicotinic acetylcholine receptors at the neuromuscular junction, preventing the binding of acetylcholine to these receptors. This leads to muscle paralysis since acetylcholine is unable to initiate muscle contraction.